FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

The Food and Drug Administration, under the Department of Health and Human Services, is offering a funding opportunity through the FDA OMHHE Health Equity Innovation Award to support innovative research aimed at strengthening minority health and advancing health equity. The award, designated as a U01 grant, seeks proposals that enhance equity in clinical research by promoting diversity in clinical trial participation, expanding the availability and quality of health data for underrepresented populations including racial and ethnic minorities, older adults, individuals with disabilities, and those from diverse geographic regions, and deepening the understanding of patient perspectives, preferences, and unmet needs among these communities. The initiative emphasizes equitable representation and inclusive research practices to address long-standing disparities in health outcomes. This funding opportunity does not permit clinical trials, but encourages research that informs and supports strategies to achieve equitable health outcomes through data innovation and community-centered approaches. The opportunity was posted on December 8, 2023, and is managed by Terrin Brown, who serves as the point of contact for inquiries related to the grant. Applicants must align their proposals with the stated goals of increasing equity in health research and must not include interventional clinical trial components. While no specific NAICS code or set-aside designation is provided, the award is open to eligible organizations pursuing research that contributes to reducing health disparities and improving the inclusivity of health data and participation in medical research.